SUPN position history
The shares of Supernus Pharmaceuticals (SUPN) that THIRD AVENUE MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q2: 2,460 shares, $72K, 0.01% of portfolio, New
- 2022 Q3: 2,460 shares, $84K, 0.02% of portfolio
- 2022 Q4: 2,460 shares, $88K, 0.02% of portfolio
- 2023 Q1: 4,920 shares, $178K, 0.03% of portfolio, Add +100.0%
- 2023 Q2: 67,062 shares, $2M, 0.33% of portfolio, Add +1263.0%
- 2023 Q3: 116,549 shares, $3.3M, 0.55% of portfolio, Add +73.8%
- 2023 Q4: 159,717 shares, $4.6M, 0.76% of portfolio, Add +37.0%
- 2024 Q1: 159,717 shares, $5.4M, 0.87% of portfolio
- 2024 Q2: 189,118 shares, $5.1M, 0.87% of portfolio, Add +18.4%
- 2024 Q3: 189,493 shares, $5.9M, 0.97% of portfolio, Add +0.2%
- 2024 Q4: 189,493 shares, $6.9M, 1.3% of portfolio
- 2025 Q1: 189,493 shares, $6.2M, 1.2% of portfolio
- 2025 Q2: 189,493 shares, $6M, 1.2% of portfolio
- 2025 Q3: 189,493 shares, $9.1M, 1.7% of portfolio
- 2025 Q4: 189,493 shares, $9.4M, 1.7% of portfolio
- 2026 Q1: 152,724 shares, $7.9M, 1.3% of portfolio, Reduce −19.4%
- 2026 Q2: 152,724 shares, $7.1M, 1.1% of portfolio
- 2026 Q3: 157,150 shares, $6.8M, 1.1% of portfolio, Add +2.9%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|